Market Place
Sourcing Support
Cartesian Therapeutics Announces New Employment Inducement Grants
02 Apr 2026 //
GLOBENEWSWIRE
Cartesian Therapeutics Unveils 2025 Financials, Business Update
09 Mar 2026 //
GLOBENEWSWIRE
Cartesian Therapeutics Joins Investor Conferences
23 Feb 2026 //
GLOBENEWSWIRE
Cartesian Therapeutics Showcases Advances, Reveals 2026 Plans
09 Jan 2026 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grants
06 Jan 2026 //
GLOBENEWSWIRE
Cartesian Therapeutics Appoints Adrian Bot To Board
18 Dec 2025 //
GLOBENEWSWIRE
Cartesian Pharma Appoints Carsten Brunn, Ph.D., as Board Chairman
30 Oct 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grants
30 Oct 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grant
03 Oct 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics Joins Investor Conferences
28 Aug 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grants
03 Jun 2025 //
GLOBENEWSWIRE
Cartesian Enrolls First Participant in Ph 3 Descartes-08 Trial
30 May 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics at H.C. Wainwright BioConnect ConfERENCE
13 May 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics Reports Q1 2025 Results and Update
08 May 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grants
02 May 2025 //
GLOBENEWSWIRE
Descartes-08 Shows Long-Term Benefits in Myasthenia Gravis Trial
08 Apr 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grants
02 Apr 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics at 24th Annual Needham Healthcare Conf.
01 Apr 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grant
06 Mar 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grants
06 Feb 2025 //
GLOBENEWSWIRE
Cartesian FDA SPA For Phase 3 AURORA Trial In Myasthenia Gravis
27 Jan 2025 //
GLOBENEWSWIRE
Cartesian Shares Strategy For mRNA Therapies In Autoimmune Diseases
13 Jan 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grants
07 Jan 2025 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grants
18 Dec 2024 //
GLOBENEWSWIRE
Cartesian Announces Positive Phase 2b Results for Descartes-08
03 Dec 2024 //
GLOBENEWSWIRE
Cartesian Presents Data from Descartes-08 Trial in Myasthenia Gravis
21 Nov 2024 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grants
08 Nov 2024 //
GLOBENEWSWIRE
Cartesian Therapeutics Q3 2024 Results & Business Update
07 Nov 2024 //
GLOBENEWSWIRE
Cartesian Therapeutics to Present at ASH 2024 Annual Meeting
05 Nov 2024 //
GLOBENEWSWIRE
Cartesian Presents Ph 2b Results Of Descartes-08 At AANEM Meeting
15 Oct 2024 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grants
04 Oct 2024 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grant
06 Sep 2024 //
GLOBENEWSWIRE
Cartesian Doses First Patient in Phase 1 mRNA CAR-T Therapy Descartes-15
03 Sep 2024 //
GLOBENEWSWIRE
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
26 Aug 2024 //
GLOBENEWSWIRE
Cartesian Therapeutics Reports Q2 2024 Results And Business Update
08 Aug 2024 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grants
07 Aug 2024 //
GLOBENEWSWIRE
Cartesian Starts Phase 2 Trial Of Descartes-08 For Lupus
04 Jul 2024 //
PHARMABIZ
Cartesian Therapeutics Announces New Employment Inducement Grant
06 Jun 2024 //
GLOBENEWSWIRE
Cartesian Gets RMAT For Descartes-08 In Myasthenia Gravis
22 May 2024 //
GLOBENEWSWIRE
Cartesian At HC Wainwright BioConnect Conference
13 May 2024 //
GLOBENEWSWIRE
Cartesian Q1 2024 Results, Business Update
08 May 2024 //
GLOBENEWSWIRE
Cartesian Announces Approval of Conversion of Series A Convertible Stock
28 Mar 2024 //
GLOBENEWSWIRE
Cartesian Therapeutics Announces New Employment Inducement Grants
05 Feb 2024 //
GLOBENEWSWIRE
Cartesian Announces Positive Data from Phase 2a Study of Descartes-08
08 Jan 2024 //
GLOBENEWSWIRE
Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities
08 Jan 2024 //
GLOBENEWSWIRE
Cartesian announces successful trial of RNA cell therapy in autoimmunity
23 Jun 2023 //
PHARMAFILE
Cartesian Therapeutics Announces Landmark Study in The Lancet Neurology
22 Jun 2023 //
BUSINESSWIRE
CAR-T cell therapy for myasthenia gravis shows promise in study by Cartesian
22 Jun 2023 //
ENDPTS
